Patient-reported Outcome, or PROs, with Abrocitinib Treatment in Patients with Moderate to Severe Atopic Dermatitis

Patient-reported Outcome, or PROs, with Abrocitinib Treatment in Patients with Moderate to Severe Atopic Dermatitis

Research Developments in Atopic Dermatitis

08/09/2020 2:08PM

Episode Synopsis "Patient-reported Outcome, or PROs, with Abrocitinib Treatment in Patients with Moderate to Severe Atopic Dermatitis"

This poster was presented by Dr. Silverberg and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Alan Fleischer.

Listen "Patient-reported Outcome, or PROs, with Abrocitinib Treatment in Patients with Moderate to Severe Atopic Dermatitis"

More episodes of the podcast Research Developments in Atopic Dermatitis